Identified a novel mercaptoacyl amino acid compound capable of potent joint inhibition of NEP, ACE, and ECE-1, offering a potential structural basis for triple metallopeptidase inhibitors.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for triple NEP/ACE/ECE inhibition; requires disease-model validation before clinical testing.
Inguimbert et al. (2002) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: